Cargando…

Angioedema after thrombolysis with tissue plasminogen activator: an airway emergency

Recombinant tissue plasminogen activator (rtPA), an enzyme that catalyzes the conversion of plasminogen to plasmin resulting in fibrinolysis, is used for the treatment of acute ischemic strokes. The use of this medication is not without complication. One complication of this therapy is angioedema. T...

Descripción completa

Detalles Bibliográficos
Autor principal:	Rathbun, Kimberly M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345090/ https://www.ncbi.nlm.nih.gov/pubmed/30697429 http://dx.doi.org/10.1093/omcr/omy112

Ejemplares similares

Angioedema Secondary to IV Tissue Plasminogen Activator Administration for Treatment of Acute Ischemic Stroke
por: Chaucer, Benjamin, et al.
Publicado: (2018)

Successful thrombolysis with recombinant tissue plasminogen activator after antagonizing dabigatran by idarucizumab: a case report
por: Gawehn, Annemarie, et al.
Publicado: (2016)

Angioedema: A Life-threatening Complication of Tissue Plasminogen Activator
por: Khalid, Muhammad, et al.
Publicado: (2018)

A Case of Oropharyngeal Angioedema Following Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Mechanical Thrombectomy
por: Shirazy, Mohamed, et al.
Publicado: (2019)

Systemic thrombolysis with recombinant tissue plasminogen activator for acute life-threatening Blalock-Taussig shunt obstruction
por: Diaz, Franco, et al.
Publicado: (2016)

Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
por: Doepp, Florian, et al.
Publicado: (2005)

Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis in a Patient with Acute Ischemic Stroke Secondary to Aortic Dissection
por: Hong, Keun-Sik, et al.
Publicado: (2009)

Retropharyngeal Hematoma Causing Airway Compromise After Tissue Plasminogen Activator Administration: A Case Report
por: Provenza, Christian, et al.
Publicado: (2023)

Dramatic thrombolysis after rapid injection of tissue plasminogen activator: A case report
por: Park, Jin-Sung, et al.
Publicado: (2019)

Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis
por: Yang, Hung-Wei, et al.
Publicado: (2012)

Acceleration of Tissue Plasminogen Activator-Mediated Thrombolysis by Magnetically Powered Nanomotors
por: Cheng, Rui, et al.
Publicado: (2014)

Successful thrombolysis of a thrombosed prosthetic mitral valve using a synthetic tissue plasminogen activator: a case report
por: Al-Sarraf, Nael, et al.
Publicado: (2010)

Microcatheter-Directed Thrombolysis Using Recombinant Tissue Plasminogen Activator for the Treatment of Acute Superior Mesenteric Artery Embolism: A Case Report
por: Kim, Yang-Won, et al.
Publicado: (2023)

The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis
por: Napolitano, Filomena, et al.
Publicado: (2021)

Screening for Plasminogen Mutations in Hereditary Angioedema Patients
por: Farkas, Henriette, et al.
Publicado: (2021)

Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis
por: HIRANO, Teruyuki
Publicado: (2015)

Thrombolysis with Systemic Recombinant Tissue Plasminogen Activator in Children: A Multicenter Retrospective Study
por: Zengin, Emine, et al.
Publicado: (2021)

Emergent Double-barrel Bypass Shortly after Intravenous Administration of Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
por: Choi, Joon-Ho, et al.
Publicado: (2016)

Tissue Plasminogen Activator-Induced Angioedema Involving a Posterior Cerebral Artery Infarct: A Case Presentation
por: Duymun, Shahnaz, et al.
Publicado: (2021)

Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage
por: Kunjukunju, Nancy, et al.
Publicado: (2011)

Successful systemic thrombolysis with rtPA in a patient with history of a life-threatening rtPA-associated orolingual angioedema
por: Pelz, Johann Otto, et al.
Publicado: (2017)

Design of a standard Iranian protocol of Intravenous thrombolysis with tissue plasminogen activator: A national project
por: Ghandehari, Kavian
Publicado: (2013)

Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke
por: Huang, Yuyou, et al.
Publicado: (2023)

Outcome after systemic thrombolysis is predicted by age and stroke severity: an open label experience with recombinant tissue plasminogen activator and tirofiban
por: Seitz, Rüdiger J., et al.
Publicado: (2012)

Life threatening angioedema in a patient on ACE inhibitor (ACEI) confined to the upper airway
por: Tharayil, Abdulgafoor Muslim, et al.
Publicado: (2014)

A challenging case of bradykinin-mediated angioedema with airway obstruction: management and therapeutic strategies
por: Nunes, Lisete Rolo, et al.
Publicado: (2023)

Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism
por: Patel, Darshan C., et al.
Publicado: (2019)

Hyperacute thrombolysis with recombinant tissue plasminogen activator of acute ischemic stroke: Feasibility and effectivity from an Indian perspective
por: Sharma, S. R., et al.
Publicado: (2008)

Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
por: Hintze, Stefan, et al.
Publicado: (2023)

A case of late-onset larynx angioedema after ranibizumab intravitreal injection: Ranibizumab-related angioedema
por: De Bernardo, Maddalena, et al.
Publicado: (2020)

A Missense Mutation of the Plasminogen Gene in a Japanese Family with Hereditary Angioedema with Normal C1 Inhibitor: Third Family Survey in Asia
por: Yakushiji, Hiromasa, et al.
Publicado: (2022)

Angioedema Involving the Larynx after Starting Apixaban
por: Williamson, Adrian, et al.
Publicado: (2019)

Reversal of cilioretinal artery occlusion with intra-arterial tissue plasminogen activator
por: McClellan, Andrew J., et al.
Publicado: (2017)

Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series
por: Dybowska, Małgorzata, et al.
Publicado: (2020)

Complicated orolingual angioedema after recombinant tissue plasminogen activator treatment in stroke patients under angiotensin converting enzyme inhibitor: Report of two cases
por: Motamed, Mohammad Reza, et al.
Publicado: (2015)

Imaging Evidence for Cerebral Hyperperfusion Syndrome after Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
por: Zhang, Yi, et al.
Publicado: (2016)

Transvenous Catheter-Based Thrombolysis With Continuous Tissue Plasminogen Activator Infusion for Refractory Thrombosis in a Patient With Behcet’s Disease
por: Arif, Saeed, et al.
Publicado: (2020)

Effect of glycated hemoglobin index and mean arterial pressure on acute ischemic stroke prognosis after intravenous thrombolysis with recombinant tissue plasminogen activator
por: Liu, Shi-Ying, et al.
Publicado: (2018)

CAN’T INTUBATE, CAN’T OXYGENATE:  A RARE CASE OF A DIFFICULT AIRWAY DUE TO NONHEREDITARY ANGIOEDEMA
por: Delalić, Điđi, et al.
Publicado: (2022)

Successful Use of Tissue Plasminogen Activator in an Adolescent Male with Pyogenic Liver Abscess
por: Zee-Cheng, Janine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ps9kbfn1903b2sriq4jih1s5hl